Suppr超能文献

急性扩张到 alpha(2)-肾上腺素受体拮抗剂揭示了动脉 alpha(2)-肾上腺素受体介导的双重收缩和扩张。

Acute dilation to alpha(2)-adrenoceptor antagonists uncovers dual constriction and dilation mediated by arterial alpha(2)-adrenoceptors.

机构信息

Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, MD 21205, USA.

出版信息

Br J Pharmacol. 2009 Nov;158(5):1344-55. doi: 10.1111/j.1476-5381.2009.00403.x. Epub 2009 Sep 28.

Abstract

BACKGROUND AND PURPOSE

In mouse tail arteries, selective alpha(2)-adrenoceptor antagonism with rauwolscine caused powerful dilation during constriction to the alpha(1)-adrenoceptor agonist phenylephrine. This study therefore assessed phenylephrine's selectivity at vascular alpha-adrenoceptors and the mechanism(s) underlying dilation to rauwolscine.

EXPERIMENTAL APPROACH

Mouse isolated tail arteries were assessed using a pressure myograph.

KEY RESULTS

The alpha(2)-adrenoceptor agonist UK14,304 caused low-maximum constriction that was inhibited by rauwolscine (3 x 10(-8) M) but not by the selective alpha(1)-adrenoceptor antagonist prazosin (10(-7) M). Concentration-effect curves to phenylephrine, cirazoline or noradrenaline were unaffected by rauwolscine but were inhibited by prazosin, which was more effective at high compared with low levels of constriction. In the presence of prazosin, rauwolscine inhibited the curves and was more effective at low compared with high levels of constriction. Although rauwolscine alone did not affect concentration-effect curves to phenylephrine, noradrenaline or cirazoline, it caused marked transient dilation when administered during constriction to these agonists. Dilation was mimicked by another alpha(2)-adrenoceptor antagonist (RX821002, 3 x 10(-8) M), was dependent on agonist selectivity, and did not occur during adrenoceptor-independent constriction (U46619). During constriction to UK14,304 plus U46619, rauwolscine or rapid removal of UK14,304 caused transient dilation that virtually abolished the combined constriction. Endothelial denudation reduced these dilator responses.

CONCLUSIONS AND IMPLICATIONS

Inhibition of alpha(2)-adrenoceptors caused transient dilation that was substantially greater than the contribution of alpha(2)-adrenoceptors to the constriction. This reflects a slowly reversing alpha(2)-adrenoceptor-mediated endothelium-dependent dilation and provides a rapid, sensitive test of alpha(2)-adrenoceptor activity. This approach also clearly emphasizes the poor selectivity of phenylephrine at vascular alpha-adrenoceptors.

摘要

背景与目的

在小鼠尾动脉中,选择性的α2-肾上腺素受体拮抗剂育亨宾能引起对α1-肾上腺素受体激动剂苯肾上腺素引起的收缩产生强大的扩张。因此,本研究评估了苯肾上腺素在血管α-肾上腺素受体上的选择性以及对育亨宾产生扩张的机制。

实验方法

使用压力肌描记器评估分离的小鼠尾动脉。

主要结果

α2-肾上腺素受体激动剂 UK14,304 引起低最大收缩,被育亨宾(3 x 10(-8) M)抑制,但不被选择性的α1-肾上腺素受体拮抗剂哌唑嗪(10(-7) M)抑制。苯肾上腺素、可乐定或去甲肾上腺素的浓度-效应曲线不受育亨宾影响,但被哌唑嗪抑制,哌唑嗪在高收缩水平比低收缩水平更有效。在哌唑嗪存在的情况下,育亨宾抑制曲线,在低收缩水平比高收缩水平更有效。虽然育亨宾本身不影响苯肾上腺素、去甲肾上腺素或可乐定的浓度-效应曲线,但在这些激动剂引起的收缩期间给予育亨宾会引起明显的短暂扩张。另一种α2-肾上腺素受体拮抗剂(RX821002,3 x 10(-8) M)模拟这种扩张,这种扩张依赖于激动剂的选择性,并且在非肾上腺素受体依赖性收缩(U46619)期间不会发生。在 UK14,304 加 U46619 引起的收缩期间,育亨宾或快速去除 UK14,304 引起短暂扩张,几乎消除了联合收缩。内皮剥脱减少了这些扩张反应。

结论和意义

抑制α2-肾上腺素受体引起短暂扩张,其程度远远大于α2-肾上腺素受体对收缩的贡献。这反映了一种缓慢逆转的α2-肾上腺素受体介导的内皮依赖性扩张,并提供了一种快速、敏感的α2-肾上腺素受体活性测试方法。这种方法也清楚地强调了苯肾上腺素在血管α-肾上腺素受体上的选择性较差。

相似文献

本文引用的文献

2
Guide to Receptors and Channels (GRAC), 3rd edition.《受体与通道指南》(GRAC),第三版。
Br J Pharmacol. 2008 Mar;153 Suppl 2(Suppl 2):S1-209. doi: 10.1038/sj.bjp.0707746.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验